Aprea Therapeutics

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE), a clinical-stage biopharmaceutical company, has announced that its Investigational New Drug (IND) application for APR-1051 has been cleared by the U.S. Food …

FDA Greenlights Aprea Therapeutics’ Investigational New Drug Application for Novel Cancer Treatment Read More



Fortress Power

Fortress Power’s Avalon High Voltage Energy Storage System Wins Approval from California Energy Commission

LANGHORNE, PA — Fortress Power’s Avalon High Voltage Energy Storage System (Avalon HV ESS) has been officially approved and listed by the California Energy Commission (CEC). This endorsement marks the …

Fortress Power’s Avalon High Voltage Energy Storage System Wins Approval from California Energy Commission Read More